dropwise over 30 minutes and the reaction maintained at 0 °C for 2 hours before stirring at room temperature for 18 hours. Deionised water (500 mL) was added and the mixture extracted three times with ethyl acetate (300 mL). The organic layers were then combined and washed three times with deionised water (500 mL), followed by saturated brine (500 mL) and dried over magnesium sulphate for one hour. The dried sample was then filtered under vacuum and ethyl acetate was removed under vacuum, yielding the hydroxyl acid as creamyyellow needles (4.60 g, 91.2%). ESI-MS (189.1, M + Na + ). 1 H NMR (500 MHz, (CD3)2CO, δ, ppm):
7.21 -7.05 (m, 5H, Ph, J = 7.13 Hz), 4.27 -4.25 (dd, 1H, αCH, J = 4.26 Hz), 3.01 -2.97 (dd, 1H, Ph-CH, J = 2.99 Hz) 2.81 -2.76 (dd, 1H, Ph-CH, J = 2.78 Hz).
Synthesis of L-phenylalanine OCA Activated charcoal (0.34, 16.3 mmol, 1 eqv) was added to a solution of diphosgene (10.28 g, 32.6 mmol, 2 eqv) and 2-hydroxy-3-phenyl propanoic acid (4.6 g, 16.3 mmol, 1 eqv) in anhydrous THF (50 mL) and stirred at room temperature, under nitrogen for 18 hours. 
Synthesis of Poly(O-benzyl-L-serine)
O-benzyl-L-serine NCA was dissolved in anhydrous DMF (10 mL) and added to a Schlenk tube which was previously evacuated and purged with nitrogen. Benzylamine (1 equivalent) in anhydrous DMF (2 mL) was injected into the reaction solution and the solution was degassed.
The reaction was then stirred under nitrogen for 96 hours, at room temperature. The polymer was precipitated in diethyl ether (250 mL) and left overnight in the freezer to facilitate greater yields. The obtained polymer was isolated via centrifugation and dried under vacuum. Yield: 74%. FTIR: 3200 cm -1 (C-H, Ar), 2850 cm -1 (C-H), 1800 cm -1 (C=O). 1 H NMR (500 MHz, TFA-d, δ, ppm): 8.51 (s, NH), 7.50 ppm (m, Ar), 4.51 -5.49 (m, CH).
Deprotection of Poly(O-benzyl-L-serine)
Poly(O-benzyl-L-serine)n was dissolved in trifluoroacetic acid (10 mL) and then added to a round bottom flask. HBr in Acetic Acid (33 wt. %, 3 mL) was added dropwise to the polymer solution. The round bottom flask was stoppered loosely and then the solution was stirred at room temperature for 18 hours. OCA-ROP from Polyserine to yield Poly(serine)-graft-(phenylalanine α-hydroxyacid)
Phe-OCA was dissolved in anhydrous DMF (5 mL) and injected into a suba-sealed Schlenk tube which was previously evacuated, nitrogen-purged and equipped with a magnetic stirrer bar. Polymer Nanoprecipitation A previously reported technique was followed for the preparation of nanoparticles (NPs) [2] .
Briefly, a solution of poly(serine)-graft-(phenylalanine α-hydroxyacid) in DMF (2 mg/mL, 2 mL) was added dropwise to PBS solution (pH 7.4, 10 mL) under vigorous stirring. The dispersion was dialysed against PBS to remove DMF and then the resultant nanoparticles were collected into clean glass vials.
Dynamic Light Scattering (DLS)
DLS analyses were performed on a Malvern Zetasizer Nano ZSP instrument equipped with a 4 mW He-Ne laser operating at a wavelength of 633 nm and an avalanche photodiode (APD)
detector. The non-invasive back scatter optic arrangement was used to collect the light scattered, at an angle of 173 °C. Samples were analysed at 37 °C in a disposable 12 mm polystyrene cuvette. Data was processed by cumulative analysis of the experimental correlation function and the diameter of the particles was computed from the diffusion coefficients using Stokes-Einstein's equation. Measurements were carried out in triplicate. Figure S5 . DLS trace depicting the particle size distribution of nanoparticles produced from poly(serine)19.6-graft-(phenylalanine α-hydroxyacid)6 Figure S6 . DLS trace depicting the particle size distribution of nanoparticles produced from poly (serine)19.6-graft-(phenylalanine α-hydroxyacid)3.1 Figure S7 . DLS trace depicting the particle size distribution of nanoparticles produced from poly(serine)18.7-graft-(phenylalanine α-hydroxyacid)3.0 Figure S8 . DLS trace depicting the particle size distribution of nanoparticles produced from poly(serine)18.7-graft-(phenylalanine α-hydroxyacid)3.0 Figure S9 . DLS trace depicting the particle size distribution of nanoparticles produced from poly(serine)9.6-graft-(phenylalanine α-hydroxyacid)5.2 Figure S10 . DLS trace depicting the particle size distribution of nanoparticles produced from poly(serine)9.6-graft-(phenylalanine α-hydroxyacid)1.8
Scanning Electron Microscopy (SEM)
Clean, dust-free pipettes were used to independently extract a droplet from the respective nanoparticle solutions. The respective drops were deposited onto SEM glass cover slips and allowed to air-dry in a fume hood. The cover slips were then mounted on individual SEM stubs using conductive tape. The samples were then sputter-coated with a thin layer of gold in a Quorum Q150RS sputter-coater. Particle size and morphology were assessed using a JEOL JSM- 
Preparation of Doxorubicin Free-Base
Doxorubicin was supplied by Sigma-Aldrich in its hydrochloride salt form. In order to appropriately screen the encapsulating and release potential of the prepared nanoparticles it was essential to convert the doxorubicin to its free-base form. In order to achieve this, doxorubicin hydrochloride (3.00 mg, 5.50 µmol, 1 equivalent) was added to a solution of triethylamine (20 uL, 55 µmol, 10 eqv.) in chloroform (3 mL) and left to stir at room temperature for 4 hours [3, 4] .
Preparation of Doxorubicin-Loaded Nanoparticles poly(serine)19.6-graft-(phenylalanine α-hydroxyacid)6 (6 mg) was dissolved in DMF (3 mL).
Doxorubicin was then encapsulated by adopting an established protocol [3, 4] . Briefly, the poly(serine)19.6-graft-(phenylalanine α-hydroxyacid)6 solution and doxorubicin-free base solution (3 mg/mL, 5.5 µmol) were added simultaneously to vigorously-stirred PBS buffer (pH 7.4, 10 mL). The NPs were dialysed against PBS buffer and obtained via lyophilisation.
Doxorubicin encapsulation resulted in a change in colour of the nanoparticle solution from clear to purple (Figure S11, inset) . Furthermore, DLS analysis of doxorubicin-loaded nanoparticles showed a slight swelling in size to around 118 nm, further confirming a successful encapsulation. Acid-Mediated Nanoparticle Degradation 0.25 mg/mL (5 mL) solutions of poly(serine)19.6-graft-(phenylalanine α-hydroxyacid)6 nanoparticles prepared in PBS buffer (pH 7.4) and acetate buffer (pH 5.0) were independently incubated at 37 °C for 48 hours. A sample was isolated from the respective media and the samples were analysed using DLS and SEM.
A sample of poly(serine)19.6-graft-(phenylalanine α-hydroxyacid)6 nanoparticles was independently incubated for 48 hours in acetate buffer (pH 5.0) before the polymer sample was diluted with DI water and dialysed initially against DI water using regenerated cellulose dialysis tubing (MWCO 1,000 kDa) for four days with multiple solvent changes. The polymer was recovered by lyophilisation and re-dialysed using the same type of dialysis tubing against chloroform for four days with multiple solvent changes. The solvent that remained within the dialysis tubing was removed in vacuo to leave the polymer that had remained within the dialysis tubing throughout the dialysis process. The 1 H NMR spectrum of this polymer is provided in Figure S13 and confirms polyester cleavage from the poly(amino acid) backbone. In vitro Cytotoxicity Assessment of Blank Nanoparticles and Doxorubicin-Loaded Nanoparticles (T47D Cells) and were cultured in DMEM (Invitrogen), supplemented with 10% (v/v) FCS (Sigma) at 37 °C in 5% CO2. The cells were certified mycoplasma-free and were short tandem, repeat-profiled for verification. 1000 T47D cells were plated in quadruplicate per well, in 96-well microplates.
After 24 hours, the doxorubicin-loaded NPs were added to the cells at varying dox concentrations. In addition, equivalent loadings of blank NPs (polymer) only, and free doxorubicin only were added to cells in independent wells. The experimental sets-up were incubated for 72 hours, at 37 °C, in a humidified 5% CO2-containing atmosphere. Then, the culture medium was replaced with a 0.5 mg/mL MTT-containing medium and the sets-up were incubated further for 3 hours, at 37 °C. The medium was replaced with DMSO. Then absorbance readings were recorded at 620 nm, using a Mithras LB 940 plate-reader. To obtain IC50 values, data were fitted to the four-parameter log (inhibitor) versus response curve in GraphPad Prism (software version 7.02). 
